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Background
Primary hyperlipidemia is genetic dyslipoproteinemia.
Without any intervention, cardiovascular diseases and
acute pancreatitis may be occurred. The detection and
appropriate management of pediatric hyperlipidemia can
have a significant impact upon the disease course and
can prevent complications.
Objects
to describe the clinical and biochemical characteristics
of hyperlipidemia in Vietnamese children and to evalu-
ate outcome of treatment.
Patients and methods
From 2007 to 2013, 30 children with primary hyperlipi-
demia were recruited and were treated with diet and/or
lipid-lowering drug therapy at the National Hospital of
Pediatrics, Hanoi, Vietnam. Clinical symptoms and bio-
chemical finding, outcome of treatment were studied.
Results: Among 30 cases from 28 families, 8 patients
were mixed hyperlipidemia (MHL), 13 patients were
hypertriglyceridemia (HT) and 9 patients were hypercho-
lesterolemia (HC). Mean age of diagnosis was 5.5 years
(1 month – 16 years). The rate of male/female was 13/17.
Clinical manifestations included hepatomegaly (4 cases),
xanthemas in the knees and elbows (5 cases), “creamy”
blood (21 cases). Twenty cases were clinical asympto-
matic. 8/28 patients had family history with hyperlipide-
mia and cardiovascular diseases. Serum cholesterol levels
of HC group was 9.2 ± 4 mmol/l. Serum triglyceride level
of HT group was 23.6 ± 9.9 mmol/l. MHL group had
hypercholesterolemia (12.1 ± 4.5 mmol/l) and hypertri-
glyceridemia (20.3 ± 10.5 mmol/l). After interventions,
HT group had the best outcome with serum triglyceride
level was 10.1 ± 4.6 mmol/l, next to MHL group with
serum cholesterole level was 5.8 ± 1.8 mmol/l, and serum
triglyceride level was 9.5 ± 5.2 mmol/l; finally, serum
cholesterole level of HC group was 12.4 ± 5.5 mmol/l.
Five infants with HT had the best outcome of treatment:
serum triglyceride level decreased from 19 - 57.6 mmol/l
to 5 - 10 mmol/l. Two patients with HC had the worsen
results (unchanged blood lipid level).
Conclusions
Primary hyperlipidemia had poor clinical manifestations
and good results of treatment. Screening for primary
hyperlipidemia help to prevent premature cardiovascular
diseases.
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